MIJ has joined together with five other companies—CareNet, Inc.; ASKLEP Inc.; Pharma Information Network, Inc.; Golden Child Co., Ltd.; and Macromill Carenet, Inc.—to establish the “SSI (Successful Support for Innovator) Consortium” with the objective of providing one-stop support for healthcare start-up companies with regard to the processes following clinical development, including market research, launch material creation, post-launch marketing activities, and post-marketing surveillances.

By providing seamless support, the SSI Consortium not only helps start-up companies accelerates the timing of stock market listings but also contributes to the enhancement of their corporate value.